![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Wu, Zhengquan; Lei, Ke; Li, Huaizhi; He, Jiali und Shi, Enxian
(27. Oktober 2022):
Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy.
In: Journal of Translational Medicine, Bd. 20, Nr. 1
[PDF, 11MB]
Schinke, Henrik; Shi, Enxian; Lin, Zhongyang; Quadt, Tanja; Kranz, Gisela; Zhou, Jiefu; Wang, Hongxia; Hess, Julia; Heuer, Steffen; Belka, Claus; Zitzelsberger, Horst; Schumacher, Udo; Genduso, Sandra; Riecken, Kristoffer; Gao, Yujing; Wu, Zhengquan; Reichel, Christoph A.; Walz, Christoph; Canis, Martin; Unger, Kristian; Baumeister, Philipp; Pan, Min und Gires, Olivier
(8. September 2022):
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
In: Molecular Cancer, Bd. 21
[PDF, 8MB]
Wu, Zhengquan; Lei, Ke; Xu, Sheng; He, Jiali und Shi, Enxian
(2022):
Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.
In: Frontiers in Immunology, Bd. 13
[PDF, 9MB]
2021
Schinke, Henrik; Pan, Min; Akyol, Merve; Zhou, Jiefu; Shi, Enxian; Kranz, Gisela; Libl, Darko; Quadt, Tanja; Simon, Florian; Canis, Martin; Baumeister, Philipp und Gires, Olivier
(2021):
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
In: Molecular Oncology, Bd. 16, Nr. 2: S. 347-367
[PDF, 2MB]